Your browser doesn't support javascript.
loading
Clinical effects of mepolizumab in patients with severe eosinophilic asthma according to background therapy: A meta-analysis.
Lugogo, Njira; Liu, Mark C; Pavord, Ian; Mitchell, Patrick D; Smith, Steven G; Mallett, Stephen; Albers, Frank C; Bradford, Eric S; Yancey, Steven W; Bel, Elisabeth H.
Afiliação
  • Lugogo N; Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Mich. Electronic address: nlugogo@med.umich.edu.
  • Liu MC; Divisions of Allergy and Clinical Immunology, Pulmonary and Critical Care Medicine, Johns Hopkins Asthma and Allergy Center, Baltimore, Md.
  • Pavord I; Respiratory Medicine Unit and Oxford Respiratory NIHR BRC, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Mitchell PD; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Smith SG; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC.
  • Mallett S; Research and Development, Statistics, Programming, and Data Standards, GSK, Stockley Park West, Uxbridge, Middlesex, United Kingdom.
  • Albers FC; Medical Department, Avillion US Inc, Northbrook, Ill.
  • Bradford ES; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC.
  • Yancey SW; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC.
  • Bel EH; Department of Respiratory Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
J Allergy Clin Immunol Pract ; 9(9): 3506-3509.e3, 2021 09.
Article em En | MEDLINE | ID: mdl-34111572

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eosinofilia Pulmonar / Asma / Antiasmáticos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eosinofilia Pulmonar / Asma / Antiasmáticos Idioma: En Ano de publicação: 2021 Tipo de documento: Article